Response to Comment to the Article "Are There Differences in Gut Microbiome in Patients with Type 2 Diabetes Treated by Metformin or Metformin and Insulin?" [Response To Letter]

Sylwia Dzięgielewska-Gęsiak,1 Edyta Fatyga,1 Magdalena Piłot,1 Aleksander Wierzgoń,2 Małgorzata Muc-Wierzgoń1 1Department of Internal Medicine Prevention, Medical University of Silesia in Katowice, Katowice, Poland; 2Department of Environmental Biotechnology, Faculty of Energy and Environmental Engi...

Full description

Saved in:
Bibliographic Details
Published in:Diabetes, metabolic syndrome and obesity metabolic syndrome and obesity, 2022-01, Vol.15, p.3989-3991
Main Authors: Dzięgielewska-Gęsiak, Sylwia, Fatyga, Edyta, Piłot, Magdalena, Wierzgoń, Aleksander, Muc-Wierzgoń, Małgorzata
Format: Article
Language:English
Subjects:
Complications and side effects
Diabetes
Diabetes therapy
Drugs
Insulin
Internal medicine
Investigations
Lifestyles
Medicine
Metformin
Microbiota
Microbiota (Symbiotic organisms)
Response to Letter
Type 2 diabetes
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Sylwia Dzięgielewska-Gęsiak,1 Edyta Fatyga,1 Magdalena Piłot,1 Aleksander Wierzgoń,2 Małgorzata Muc-Wierzgoń1 1Department of Internal Medicine Prevention, Medical University of Silesia in Katowice, Katowice, Poland; 2Department of Environmental Biotechnology, Faculty of Energy and Environmental Engineering, Silesian University of Technology, Gliwice, Poland Correspondence: Sylwia Dzięgielewska-Gęsiak, Department of Internal Medicine Prevention, Medical University of Silesia in Katowice, 41-902 Bytom, Piekarska 18 St, Katowice, Poland, Tel/Fax +48/32/39-76-527, Email [email protected] View the original paper by Dr Dzięgielewska-Gęsiak and colleagues This is in response to the Letter to the Editor
ISSN:1178-7007
1178-7007
DOI:10.2147/DMSO.S400278